Figure 2
Patient and physician-reported treatment benefit after switching from tolterodine ER to fesoterodine. CGI-I, Global Improvement subscale; TBS, Treatment Benefit Scale.
Figure 2 | BMC Urology
Patient and physician-reported treatment benefit after switching from tolterodine ER to fesoterodine. CGI-I, Global Improvement subscale; TBS, Treatment Benefit Scale.